跳到主文本

Investor Relations

Nitto always aims for fair disclosure to ensure that our investors can properly evaluate our corporate value.

Nitto always aims for fair disclosure to ensure that our investors can properly evaluate our corporate value.

What's New RSS

The Nitto website is currently under system maintenance. Please try again later.
2016/Nov/11 Bristol-Myers Squibb 与 Nitto Denko 签署针对晚期非酒精性脂肪性肝炎 (NASH) 和 NASH 继发性肝硬化的靶向 siRNA 治疗的独家全球许可协议
2016/Nov/07 Nitto旗下海德能®参展2016 WaterEX 北京水展
2016/Nov/02 Nitto节能窗膜“PENJEREX®”亮相“中国国际工业博览会”
Notice
 
Please be advised that except for current and past facts, the performance outlooks and business strategies presented in this Website are based on projections and judgments by NITTO DENKO management, and may differ from the actual performance.

Moreover, as it is not the intention of this Website to solicit any investments in NITTO DENKO stocks, visitors intending to do so are advised to make their investment decisions solely based on their own judgment.

返回页首